Christian Mair - Search Results

Year	Number of Results
2015	1
2018	1
2019	2
2020	3
2021	2
2023	1
2024	0

1

⁶⁸Ga-labelled desferrioxamine-B for bacterial infection imaging.

Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Pfister J, Mair C, Novy Z, Popper M, Hajduch M, Decristoforo C. Petrik M, et al. Among authors: mair c. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):372-382. doi: 10.1007/s00259-020-04948-y. Epub 2020 Jul 30. Eur J Nucl Med Mol Imaging. 2021. PMID: 32734456 Free PMC article.

2

Radiation exposure after ¹⁷⁷Lu-DOTATATE and ¹⁷⁷Lu-PSMA-617 therapy.

Mair C, Warwitz B, Fink K, Scarpa L, Nilica B, Maffey-Steffan J, Buxbaum S, Virgolini IJ. Mair C, et al. Ann Nucl Med. 2018 Aug;32(7):499-502. doi: 10.1007/s12149-018-1264-x. Epub 2018 May 23. Ann Nucl Med. 2018. PMID: 29797003

3

Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study.

Fresacher K, Helbok A, Reiser M, Blass S, Rangger C, Mair C, von Guggenberg E, Decristoforo C, Andreae F, Zimmer A. Fresacher K, et al. Among authors: mair c. Eur J Pharm Sci. 2019 Nov 1;139:105063. doi: 10.1016/j.ejps.2019.105063. Epub 2019 Sep 2. Eur J Pharm Sci. 2019. PMID: 31487537

4

Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of ¹⁷⁷Lu-Labeled Peptide Analogs Targeting CCK2R.

Hörmann AA, Klingler M, Rangger C, Mair C, Joosten L, Franssen GM, Laverman P, von Guggenberg E. Hörmann AA, et al. Among authors: mair c. Pharmaceutics. 2023 Feb 28;15(3):796. doi: 10.3390/pharmaceutics15030796. Pharmaceutics. 2023. PMID: 36986657 Free PMC article.

5

The ⁶⁸Ga/¹⁷⁷Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.

Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I. Maffey-Steffan J, et al. Among authors: mair c. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):695-712. doi: 10.1007/s00259-019-04583-2. Epub 2019 Nov 27. Eur J Nucl Med Mol Imaging. 2020. PMID: 31776632 Free PMC article.

6

Radiopharmaceutical Formulation and Preclinical Testing of ⁶⁸Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial.

Hörmann AA, Klingler M, Rangger C, Mair C, Decristoforo C, Uprimny C, Virgolini IJ, von Guggenberg E. Hörmann AA, et al. Among authors: mair c. Pharmaceuticals (Basel). 2021 Jun 16;14(6):575. doi: 10.3390/ph14060575. Pharmaceuticals (Basel). 2021. PMID: 34208516 Free PMC article.

7

N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.

Lackner M, Binder U, Reindl M, Gönül B, Fankhauser H, Mair C, Nagl M. Lackner M, et al. Among authors: mair c. Antimicrob Agents Chemother. 2015 Oct;59(10):6454-62. doi: 10.1128/AAC.00957-15. Epub 2015 Aug 3. Antimicrob Agents Chemother. 2015. PMID: 26239996 Free PMC article.

8

Correction to: The ⁶⁸Ga/¹⁷⁷Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.

Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I. Maffey-Steffan J, et al. Among authors: mair c. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):740. doi: 10.1007/s00259-019-04660-6. Eur J Nucl Med Mol Imaging. 2020. PMID: 31863137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year